Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-11-16 Sale |
2021-11-18 8:14 pm |
Vor Biopharma Inc. | VOR | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC Schwab Andrew J. 10% Owner |
330,706 | $15.3 | $5,059,802 | 1,766,634 (Indirect) |
View |
2021-11-16 Sale |
2021-11-18 8:10 pm |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
330,706 | $15.3 | $5,059,802 | 1,766,634 (Indirect) |
View |
2021-02-09 Purchase |
2021-02-09 6:25 pm |
Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,979,566 | $18 | $53,632,188 | 1,825,326 (Indirect) |
View |
2021-02-09 Purchase |
2021-02-09 6:03 pm |
Vor Biopharma Inc. | VOR | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC Schwab Andrew J. 10% Owner |
555,555 | $18 | $9,999,990 | 1,858,470 (Indirect) |
View |
2021-02-09 Purchase |
2021-02-09 5:15 pm |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
555,555 | $18 | $9,999,990 | 1,875,370 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-09-01 Option Award |
2022-09-06 4:14 pm |
N/A 2032-08-31 |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
86,000 | $0 | 201,269 (Direct) |
View |
2022-06-14 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
16,911 | $0 | 16,911 (Indirect) |
View |
2022-06-14 Option Award |
2022-06-16 5:12 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | Resnick Joshua Director |
16,911 | $0 | 16,911 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 5:11 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | Patterson Matthew R Director |
16,911 | $0 | 16,911 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 5:09 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
16,911 | $0 | 16,911 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 5:07 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
16,911 | $0 | 16,911 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 5:05 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | Lubner David Charles Director |
16,911 | $0 | 16,911 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 5:03 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | Beckman Daniella Director |
16,911 | $0 | 16,911 (Direct) |
View |
2022-02-01 Option Award |
2022-02-03 4:36 pm |
N/A 2032-01-31 |
Vor Biopharma Inc. | VOR | Slapak Christopher Chief Medical Officer |
116,000 | $0 | 116,000 (Direct) |
View |
2022-02-01 Option Award |
2022-02-03 4:32 pm |
N/A 2032-01-31 |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
2022-02-01 Option Award |
2022-02-03 4:28 pm |
N/A 2032-01-31 |
Vor Biopharma Inc. | VOR | Chakraborty Tirtha Chief Scientific Officer |
101,000 | $0 | 101,000 (Direct) |
View |
2022-02-01 Option Award |
2022-02-03 4:25 pm |
N/A 2032-01-31 |
Vor Biopharma Inc. | VOR | ANG ROBERT President and CEO |
376,000 | $0 | 376,000 (Direct) |
View |
2021-08-17 Exercise |
2021-08-19 4:02 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Chakraborty Tirtha Chief Scientific Officer |
17,446 | $1.36 | 49,780 (Direct) |
View |
2021-08-17 Exercise |
2021-08-19 4:02 pm |
N/A 2029-09-24 |
Vor Biopharma Inc. | VOR | Chakraborty Tirtha Chief Scientific Officer |
17,446 | $0 | 49,780 (Direct) |
View |
2021-04-01 Other |
2021-04-05 4:33 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
998,382 | $43.1 | 11,363,629 (Indirect) |
View |
2021-02-09 Conversion |
2021-02-09 7:40 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Alexandria Venture Investments LLC 10% Owner |
4,128,956 | $0 | 282,804 (Direct) |
View |
2021-02-09 Conversion |
2021-02-09 6:25 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
104,288,206 | $0 | 1,825,326 (Indirect) |
View |
2021-02-09 Conversion |
2021-02-09 6:03 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC Schwab Andrew J. 10% Owner |
88,184,384 | $0 | 1,858,470 (Indirect) |
View |
2021-02-09 Conversion |
2021-02-09 5:22 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
51,610 | $0 | 29,269 (Direct) |
View |
2021-02-09 Conversion |
2021-02-09 5:22 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Chakraborty Tirtha Chief Scientific Officer |
51,610 | $0 | 3,534 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 5:17 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | Resnick Joshua Director |
16,900 | $0 | 16,900 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 5:16 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | Patterson Matthew R Director |
16,900 | $0 | 16,900 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 5:15 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
16,900 | $0 | 1,875,370 (Direct) |
View |
2021-02-09 Conversion |
2021-02-09 5:15 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
88,184,384 | $0 | 1,875,370 (Indirect) |
View |
2021-02-05 Option Award |
2021-02-09 5:14 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
16,900 | $0 | 16,900 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 5:13 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | Lubner David Charles Director |
16,900 | $0 | 16,900 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 5:11 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | Beckman Daniella Director |
16,900 | $0 | 16,900 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 5:10 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | ANG ROBERT President and CEO |
51,060 | $0 | 51,060 (Direct) |
View |
Ownership |
2021-02-04 9:58 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Alexandria Venture Investments LLC 10% Owner |
0 | $0 | 282,804 (Direct) |
View |
Ownership |
2021-02-04 9:58 pm |
N/A 2030-08-24 |
Vor Biopharma Inc. | VOR | Slapak Christopher Chief Medical Officer |
0 | $0 | 306,207 (Direct) |
View |
Ownership |
2021-02-04 9:52 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | PureTech Health LLC 10% Owner |
0 | $0 | 3,207,200 (Direct) |
View |
Ownership |
2021-02-04 9:50 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC Schwab Andrew J. 10% Owner |
0 | $0 | 6,136,874 (Indirect) |
View |
Ownership |
2021-02-04 9:50 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Patterson Matthew R Director |
0 | $0 | 41,196 (Direct) |
View |
Ownership |
2021-02-04 9:49 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
0 | $0 | 6,136,874 (Indirect) |
View |
Ownership |
2021-02-04 9:48 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
0 | $0 | 50,394 (Direct) |
View |
Ownership |
2021-02-04 9:47 pm |
N/A 2030-08-24 |
Vor Biopharma Inc. | VOR | Lubner David Charles Director |
0 | $0 | 41,196 (Direct) |
View |
Ownership |
2021-02-04 9:46 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 7,123,025 (Indirect) |
View |
Ownership |
2021-02-04 9:46 pm |
N/A 2029-12-16 |
Vor Biopharma Inc. | VOR | Kassim Sadik Chief Technology Officer |
0 | $0 | 298,643 (Direct) |
View |
Ownership |
2021-02-04 9:45 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
0 | $0 | 280,361 (Direct) |
View |